Topic: Genotoxicity/Mutagenicity
Method Description
The Green Screen HCTM (GSHC) assay is an in vitro human cell-based genotoxicity test method intended to predict the in vivo genotoxic potential of chemicals.
Specifically, the GSHC is a microplate format genotoxicity plus cytotoxicity screening assay which uses the DNA damage-inducible "Growth Arrest and DNA Damage 45 alpha" (GADD45a) - Green Fluorescent Protein (GFP) reporter gene, expressed in the p53-competent human lymphoblastoid TK6 cell line.
The Submitter has proposed the test method for both regulatory and non-regulatory genotoxicity assessment: (A) for compound discovery and development screening applications; (B) as additional test to be used in Option2 under ICH S2(R1); (C) as stand-alone test alternative to the in vitro battery; (D) to support weight of evidence arguments in regulatory safety assessment of in vitro genotoxicity battery data - where genotoxicity data from other tests are conflicting.
Track Approval Status
-
Submission
-
Validation
-
Peer-review
-
Recommendation
-
Regulatory acceptance/Standards
Step | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Submission | Show status | ||||||||||||||||||||||||
|
|||||||||||||||||||||||||
Validation | |||||||||||||||||||||||||
Peer-review | |||||||||||||||||||||||||
Recommendation | |||||||||||||||||||||||||
Regulatory acceptance/Standards | |||||||||||||||||||||||||